patents
Business of IP – Understanding and Creating Value
By Anders Isaksson | Posted on March 23, 2022
In this article, Anders Isaksson explores some of the key factors and motivators for why companies small or large should obtain intellectual property. The aim is to help you understand when and how you can create value from IP, especially when considering the long and short-term goals of a company. Venture Capital Whether you are...
Tags: business, designs, IP, patents, trademarks
The Business of IP – Understanding and Creating Value: Part 6 – Costs of IP
By Anders Isaksson | Posted on January 17, 2022
In this six-part series, Anders Isaksson explores some of the critical factors and motivators for why companies, small or large, should obtain intellectual property. The aim is to help you understand when and how you can create value from IP, especially when considering a company’s long and short-term goals. In the previous article in this...
Tags: costs, designs, patents, trademarks
IP Pitfalls When Creating a New Product Line (Or a New Company) – Part 2: Patents, Designs and IP Contract Considerations
By AWA | Posted on December 2, 2021
When creating a new product line or starting a new company, many types of considerations and preparations are necessary. Experience shows that the IP considerations are often near the bottom of the to-do list. However, not giving IP due focus may lead to substantial problems and headaches down the road. Some of these problems can...
Tags: contracts, designs, patents
The Business of IP – Understanding and Creating Value: Part 5 – Negotiations
By Anders Isaksson | Posted on October 27, 2021
In this six-part series, Anders Isaksson explores some of the critical factors and motivators for why companies, small or large, should obtain intellectual property. The aim is to help you understand when and how you can create value from IP, especially when considering a company’s long and short-term goals. In the previous article in this...
Filed under:
Tags: desings, Intellectual Property, negotiations, patents, trademarks
Determining the Value of Patents during an Investment or Sale
By Joanna Applequist, Mikael Henriksson | Posted on October 1, 2021
Joanna Applequist and Mikael Henriksson speak on IP matters that companies should consider preparing for during an investment or sale during this seminar hosted by Stockholm Science City. Joanna and Mikael were joined by David Bejker from Affibody AB and Jonas Jendi from Industrifonden. This webinar is in Swedish.
Tags: investment, patents, sale, strategy
EPO’s highest legal authority to decide if post-published data can support inventive step
By Michael Bech Sommer | Posted on August 17, 2021
The European Patent Office’s (EPO) highest legal authority, the Enlarged Board of Appeal, is about to be referred questions from the Board of Appeal (BoA) on whether data produced after the filing date of a patent application (post-published data) can be used as the sole basis to support the inventive step of a claim. Essentially,...
Tags: BoA, data, EPO, patents, post-filing data
The Business of IP – Understanding and Creating Value: Part 4 – Spin-Offs
By Anders Isaksson | Posted on July 27, 2021
In this six-part series, Anders Isaksson explores some of the critical factors and motivators for why companies, small or large, should obtain intellectual property. The aim is to help you understand when and how you can create value from IP, especially when considering a company’s long and short-term goals. In the previous article in this...
Tags: design, Intellectual Property, patents, spin-off, trademarks
Was this the last hurdle for German UPCA Ratification?
By Niklas Mattsson | Posted on July 12, 2021
At the end of 2020, German ratification of the Agreement on a Unified Patent Court (UPCA) looked promising as the German parliament (Bundestag) was approved with the required two-thirds majority. However, two applications before the German Constitutional Court (FCC) for preliminary injunctions against ratification delayed the final steps for the act to be promulgated. This...
MedTrace receives $30 million investment fuelling US expansion and new business area
By AWA | Posted on May 13, 2021
AWA’s client MedTrace Pharma A/S has received nearly $30 million from Swiss-based Swisscanto Invest and Danish investors ATP and BankInvest. MedTrace has developed a fully automated technology that makes radioactive water clinically available to patients in need of diagnostic heart imaging. Radioactive water (15O-water), currently used on occasion for various scans, will now be produced...
The Business of IP – Understanding and Creating Value: Part 3 – Mergers and Collaborations
By Anders Isaksson | Posted on April 20, 2021
In this six-part series, Anders Isaksson explores some of the critical factors and motivators for why companies, small or large, should obtain intellectual property. The aim is to help you understand when and how you can create value from IP, especially when considering a company’s long and short-term goals. In the previous article in this...
Tags: collaborations, due dilligence, Intellectual Property, mergers, patents, trademarks
Recent contributors
Partner, European Patent Attorney
Senior Associate, Attorney at Law
Partner, Attorney at Law, Group Vice President
Partner, Attorney at Law, Business Area Manager
Senior Counsel, European Patent Attorney
